Zilong Xu

机构：Xiamen University · ORCID：0009-0001-5619-5834

发表论文 15 篇 · 总被引 275 次 · h-index 6

代表论文

• Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade (2022 · Journal for ImmunoTherapy of Cancer · 被引 76)
• Intratumoral Delivery of a PD-1–Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade (2020 · Cancer Immunology Research · 被引 67)
• Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1 (2024 · Nature Communications · 被引 65)
• Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma (2019 · Molecular Therapy — Oncolytics · 被引 31)
• SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T-cell Activity in Hepatocellular Carcinoma (2025 · Cancer Research · 被引 25)
• A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D (2022 · Antiviral Research · 被引 11)